179 related articles for article (PubMed ID: 7750805)
1. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats.
Maitra I; Serbinova E; Trischler H; Packer L
Free Radic Biol Med; 1995 Apr; 18(4):823-9. PubMed ID: 7750805
[TBL] [Abstract][Full Text] [Related]
2. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats.
Maitra I; Serbinova E; Tritschler HJ; Packer L
Biochem Biophys Res Commun; 1996 Apr; 221(2):422-9. PubMed ID: 8619871
[TBL] [Abstract][Full Text] [Related]
3. In vivo inhibition of l-buthionine-(S,R)-sulfoximine-induced cataracts by a novel antioxidant, N-acetylcysteine amide.
Carey JW; Pinarci EY; Penugonda S; Karacal H; Ercal N
Free Radic Biol Med; 2011 Mar; 50(6):722-9. PubMed ID: 21172425
[TBL] [Abstract][Full Text] [Related]
4. Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage.
Mårtensson J; Steinherz R; Jain A; Meister A
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8727-31. PubMed ID: 2813421
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin.
Abe M; Reiter RJ; Orhii PB; Hara M; Poeggeler B
J Pineal Res; 1994 Sep; 17(2):94-100. PubMed ID: 7869232
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts.
Packer L
Ann N Y Acad Sci; 1994 Nov; 738():257-64. PubMed ID: 7832436
[No Abstract] [Full Text] [Related]
7. Protection from hyperbaric oxidant stress by administration of buthionine sulfoximine.
Komadina KH; Duncan CA; Bryan CL; Jenkinson SG
J Appl Physiol (1985); 1991 Jul; 71(1):352-8. PubMed ID: 1680846
[TBL] [Abstract][Full Text] [Related]
8. Progression of mouse buthionine sulfoximine cataracts in vitro is inhibited by thiols or ascorbate.
Calvin HI; Zhu G; Wu J; Banerjee U; Fu JS
Exp Eye Res; 1997 Sep; 65(3):341-7. PubMed ID: 9299171
[TBL] [Abstract][Full Text] [Related]
9. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
Le CT; Hollaar L; van der Valk EJ; van der Laarse A
J Mol Cell Cardiol; 1993 May; 25(5):519-28. PubMed ID: 8104252
[TBL] [Abstract][Full Text] [Related]
10. Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine sulfoximine: preventive actions of melatonin.
Li ZR; Reiter RJ; Fujimori O; Oh CS; Duan YP
J Pineal Res; 1997 Apr; 22(3):117-23. PubMed ID: 9213264
[TBL] [Abstract][Full Text] [Related]
11. Buthionine sulfoximine-induced glutathione depletion. Its effect on antioxidants, lipid peroxidation and calcium homeostasis in the lung.
Thanislass J; Raveendran M; Devaraj H
Biochem Pharmacol; 1995 Jul; 50(2):229-34. PubMed ID: 7632167
[TBL] [Abstract][Full Text] [Related]
12. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice.
Calvin HI; Medvedovsky C; Worgul BV
Science; 1986 Aug; 233(4763):553-5. PubMed ID: 3726547
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
[TBL] [Abstract][Full Text] [Related]
14. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects.
Mãrtensson J; Meister A
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4656-60. PubMed ID: 2052548
[TBL] [Abstract][Full Text] [Related]
15. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants.
Han D; Sen CK; Roy S; Kobayashi MS; Tritschler HJ; Packer L
Am J Physiol; 1997 Nov; 273(5):R1771-8. PubMed ID: 9374822
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with alpha-lipoic acid enantiomers.
Lockhart B; Jones C; Cuisinier C; Villain N; Peyroulan D; Lestage P
Brain Res; 2000 Feb; 855(2):292-7. PubMed ID: 10677603
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress.
Mårtensson J; Jain A; Stole E; Frayer W; Auld PA; Meister A
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9360-4. PubMed ID: 1681551
[TBL] [Abstract][Full Text] [Related]
18. Lens GSH depletion and electrolyte changes preceding cataracts induced by buthionine sulfoximine in suckling mice.
Calvin HI; von Hagen S; Hess JL; Patel SA; Fu SC
Exp Eye Res; 1992 Apr; 54(4):621-6. PubMed ID: 1623947
[TBL] [Abstract][Full Text] [Related]
19. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).
Griffith OW; Meister A
J Biol Chem; 1979 Aug; 254(16):7558-60. PubMed ID: 38242
[TBL] [Abstract][Full Text] [Related]
20. The effect of in utero administration of buthionine sulfoximine on rat development.
Reyes E; Ott S; Robinson B; Contreras R
Pharmacol Biochem Behav; 1995 Apr; 50(4):491-7. PubMed ID: 7617692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
